EPRX short interest
Eupraxia Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 6,798,798 |
|---|---|
| Change vs prior report | -783,557 (-10.3%) |
| Change over six months | +167.5% |
| Days to cover | 11.07 (sector: 3.78) |
| Average daily volume | 614,408 |
| Rank in Healthcare | #88 of 922 by days to cover |
EPRX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 6,798,798 | -10.3% | 11.07 | 614,408 |
| 2026-09-15 | 7,582,355 | +6.6% | 11.25 | 673,955 |
| 2026-08-31 | 7,112,440 | +12.2% | 18.45 | 385,471 |
| 2026-08-14 | 6,336,985 | +4.9% | 28.76 | 220,310 |
| 2026-07-31 | 6,043,489 | +2.1% | 12.99 | 465,259 |
| 2026-07-15 | 5,921,701 | +8.4% | 25.74 | 230,018 |
| 2026-06-30 | 5,462,325 | +18.8% | 8.99 | 607,348 |
| 2026-06-15 | 4,597,670 | +12.7% | 16.27 | 282,503 |
| 2026-05-29 | 4,078,992 | +14.5% | 12.26 | 332,600 |
| 2026-05-15 | 3,561,791 | +15.8% | 23.75 | 149,950 |
| 2026-04-30 | 3,076,432 | +19.8% | 17.77 | 173,114 |
| 2026-04-15 | 2,568,242 | +1.0% | 16.35 | 157,120 |
| 2026-03-31 | 2,541,747 | +1.6% | 10.48 | 242,462 |
| 2026-03-13 | 2,500,950 | +26.3% | 11.76 | 212,578 |
| 2026-02-27 | 1,979,996 | +19.4% | 5.81 | 340,549 |
| 2026-02-13 | 1,658,534 | +12.7% | 9.03 | 183,702 |
| 2026-01-30 | 1,471,385 | +2.1% | 9.47 | 155,343 |
| 2026-01-15 | 1,441,076 | +9.9% | 7.80 | 184,764 |
| 2025-12-31 | 1,311,773 | +138.8% | 7.65 | 171,382 |
| 2025-12-15 | 549,299 | +30.1% | 5.65 | 97,160 |
| 2025-11-28 | 422,094 | +67.7% | 2.69 | 156,901 |
| 2025-11-14 | 252,163 | -5.0% | 1.37 | 184,189 |
| 2025-10-31 | 265,495 | +3.6% | 5.13 | 51,784 |
| 2025-10-15 | 256,174 | -13.5% | 4.30 | 59,554 |
| 2025-09-30 | 296,130 | +59.9% | 1.00 | 331,378 |
import finzdata as yf
yf.Ticker("EPRX").short_interest # every report since 2017
yf.Client().short_interest(["EPRX"], start="2018-01-01")Healthcare short interest · EPRX price history · Who owns EPRX · All short interest